Best, S., Lam, V., Liu, T., Bruss, N., Kittai, A., Danilova, O. V., . . . Danilov, A. V. (2020). Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells. Leukemia.
Chicago-tyylinen lähdeviittausBest, Scott, et al. "Immunomodulatory Effects of Pevonedistat, a NEDD8-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia-derived T Cells." Leukemia 2020.
MLA-viiteBest, Scott, et al. "Immunomodulatory Effects of Pevonedistat, a NEDD8-activating Enzyme Inhibitor, in Chronic Lymphocytic Leukemia-derived T Cells." Leukemia 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.